268 related articles for article (PubMed ID: 18562529)
41. Maedi-visna virus Vif protein uses motifs distinct from HIV-1 Vif to bind zinc and the cofactor required for A3 degradation.
Knecht KM; Hu Y; Rubene D; Cook M; Ziegler SJ; Jónsson SR; Xiong Y
J Biol Chem; 2021; 296():100045. PubMed ID: 33465707
[TBL] [Abstract][Full Text] [Related]
42. MDM2 is a novel E3 ligase for HIV-1 Vif.
Izumi T; Takaori-Kondo A; Shirakawa K; Higashitsuji H; Itoh K; Io K; Matsui M; Iwai K; Kondoh H; Sato T; Tomonaga M; Ikeda S; Akari H; Koyanagi Y; Fujita J; Uchiyama T
Retrovirology; 2009 Jan; 6():1. PubMed ID: 19128510
[TBL] [Abstract][Full Text] [Related]
43. CAEV Vif Hijacks ElonginB/C, CYPA and Cullin5 to Assemble the E3 Ubiquitin Ligase Complex Stepwise to Degrade oaA3Z2-Z3.
Zhao Z; Li Z; Huan C; Wang H; Su X; Zhang W
Front Microbiol; 2019; 10():565. PubMed ID: 30941116
[TBL] [Abstract][Full Text] [Related]
44. The Vif protein of human immunodeficiency virus type 1 is posttranslationally modified by ubiquitin.
Dussart S; Courcoul M; Bessou G; Douaisi M; Duverger Y; Vigne R; Decroly E
Biochem Biophys Res Commun; 2004 Feb; 315(1):66-72. PubMed ID: 15013426
[TBL] [Abstract][Full Text] [Related]
45. The SOCS box encodes a hierarchy of affinities for Cullin5: implications for ubiquitin ligase formation and cytokine signalling suppression.
Babon JJ; Sabo JK; Zhang JG; Nicola NA; Norton RS
J Mol Biol; 2009 Mar; 387(1):162-74. PubMed ID: 19385048
[TBL] [Abstract][Full Text] [Related]
46. VHL-box and SOCS-box domains determine binding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases.
Kamura T; Maenaka K; Kotoshiba S; Matsumoto M; Kohda D; Conaway RC; Conaway JW; Nakayama KI
Genes Dev; 2004 Dec; 18(24):3055-65. PubMed ID: 15601820
[TBL] [Abstract][Full Text] [Related]
47. Characterization of Cullin-box sequences that direct recruitment of Cul2-Rbx1 and Cul5-Rbx2 modules to Elongin BC-based ubiquitin ligases.
Mahrour N; Redwine WB; Florens L; Swanson SK; Martin-Brown S; Bradford WD; Staehling-Hampton K; Washburn MP; Conaway RC; Conaway JW
J Biol Chem; 2008 Mar; 283(12):8005-13. PubMed ID: 18187417
[TBL] [Abstract][Full Text] [Related]
48. Human immunodeficiency virus type 1 Vif induces cell cycle delay via recruitment of the same E3 ubiquitin ligase complex that targets APOBEC3 proteins for degradation.
DeHart JL; Bosque A; Harris RS; Planelles V
J Virol; 2008 Sep; 82(18):9265-72. PubMed ID: 18596088
[TBL] [Abstract][Full Text] [Related]
49. Ring finger protein ZIN interacts with human immunodeficiency virus type 1 Vif.
Feng F; Davis A; Lake JA; Carr J; Xia W; Burrell C; Li P
J Virol; 2004 Oct; 78(19):10574-81. PubMed ID: 15367624
[TBL] [Abstract][Full Text] [Related]
50. Zinc chelation inhibits HIV Vif activity and liberates antiviral function of the cytidine deaminase APOBEC3G.
Xiao Z; Ehrlich E; Luo K; Xiong Y; Yu XF
FASEB J; 2007 Jan; 21(1):217-22. PubMed ID: 17135358
[TBL] [Abstract][Full Text] [Related]
51. Structural basis for hijacking CBF-β and CUL5 E3 ligase complex by HIV-1 Vif.
Guo Y; Dong L; Qiu X; Wang Y; Zhang B; Liu H; Yu Y; Zang Y; Yang M; Huang Z
Nature; 2014 Jan; 505(7482):229-33. PubMed ID: 24402281
[TBL] [Abstract][Full Text] [Related]
52. Multimeric complexes among ankyrin-repeat and SOCS-box protein 9 (ASB9), ElonginBC, and Cullin 5: insights into the structure and assembly of ECS-type Cullin-RING E3 ubiquitin ligases.
Thomas JC; Matak-Vinkovic D; Van Molle I; Ciulli A
Biochemistry; 2013 Aug; 52(31):5236-46. PubMed ID: 23837592
[TBL] [Abstract][Full Text] [Related]
53. Distinct determinants in HIV-1 Vif and human APOBEC3 proteins are required for the suppression of diverse host anti-viral proteins.
Zhang W; Chen G; Niewiadomska AM; Xu R; Yu XF
PLoS One; 2008; 3(12):e3963. PubMed ID: 19088851
[TBL] [Abstract][Full Text] [Related]
54. Structural analysis of viral infectivity factor of HIV type 1 and its interaction with A3G, EloC and EloB.
da Costa KS; Leal E; dos Santos AM; Lima e Lima AH; Alves CN; Lameira J
PLoS One; 2014; 9(2):e89116. PubMed ID: 24586532
[TBL] [Abstract][Full Text] [Related]
55. The assembly of Vif ubiquitin E3 ligase for APOBEC3 degradation.
Kim DY
Arch Pharm Res; 2015 Apr; 38(4):435-45. PubMed ID: 25408426
[TBL] [Abstract][Full Text] [Related]
56. Interactions between HIV-1 Vif and human ElonginB-ElonginC are important for CBF-β binding to Vif.
Wang X; Wang X; Zhang H; Lv M; Zuo T; Wu H; Wang J; Liu D; Wang C; Zhang J; Li X; Wu J; Yu B; Kong W; Yu X
Retrovirology; 2013 Aug; 10():94. PubMed ID: 23988114
[TBL] [Abstract][Full Text] [Related]
57. Molecular architecture of the ankyrin SOCS box family of Cul5-dependent E3 ubiquitin ligases.
Muniz JR; Guo K; Kershaw NJ; Ayinampudi V; von Delft F; Babon JJ; Bullock AN
J Mol Biol; 2013 Sep; 425(17):3166-77. PubMed ID: 23806657
[TBL] [Abstract][Full Text] [Related]
58. Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity.
Newman EN; Holmes RK; Craig HM; Klein KC; Lingappa JR; Malim MH; Sheehy AM
Curr Biol; 2005 Jan; 15(2):166-70. PubMed ID: 15668174
[TBL] [Abstract][Full Text] [Related]
59. Core-binding factor β increases the affinity between human Cullin 5 and HIV-1 Vif within an E3 ligase complex.
Salter JD; Lippa GM; Belashov IA; Wedekind JE
Biochemistry; 2012 Nov; 51(44):8702-4. PubMed ID: 23098073
[TBL] [Abstract][Full Text] [Related]
60. Muf1, a novel Elongin BC-interacting leucine-rich repeat protein that can assemble with Cul5 and Rbx1 to reconstitute a ubiquitin ligase.
Kamura T; Burian D; Yan Q; Schmidt SL; Lane WS; Querido E; Branton PE; Shilatifard A; Conaway RC; Conaway JW
J Biol Chem; 2001 Aug; 276(32):29748-53. PubMed ID: 11384984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]